These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 29213475)
1. Cluster analysis of cognitive performance in a sample of patients with Parkinson's disease. Souza CP; Oliveira GN; Foss MP; Tumas V Dement Neuropsychol; 2016; 10(4):315-319. PubMed ID: 29213475 [TBL] [Abstract][Full Text] [Related]
2. The interlocking finger test in patients with Parkinson's disease and healthy subjects. Souza CP; Oliveira GN; Foss MP; Tumas V J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261 [TBL] [Abstract][Full Text] [Related]
3. An analysis of the cognitive items of the movement disorders society checklist for the diagnosis of dementia in patients with Parkinson's disease. Oliveira GN; Souza CP; Foss MP; Tumas V Parkinsonism Relat Disord; 2015 Oct; 21(10):1260-3. PubMed ID: 26289825 [TBL] [Abstract][Full Text] [Related]
4. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment. Simon-Gozalbo A; Rodriguez-Blazquez C; Forjaz MJ; Martinez-Martin P Front Neurol; 2020; 11():731. PubMed ID: 32849203 [No Abstract] [Full Text] [Related]
5. Global cognitive performance is associated with sleep efficiency measured by polysomnography in patients with Parkinson's disease. Sobreira EST; Sobreira-Neto MA; Pena-Pereira MA; Chagas MHN; Fernandes RMF; Eckeli AL; Tumas V Psychiatry Clin Neurosci; 2019 May; 73(5):248-253. PubMed ID: 30636105 [TBL] [Abstract][Full Text] [Related]
6. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease]. Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589 [TBL] [Abstract][Full Text] [Related]
8. CERAD test performance and cognitive impairment in Parkinson's disease. Karrasch M; Laatu S; Martikainen K; Marttila R Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316 [TBL] [Abstract][Full Text] [Related]
9. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition. Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230 [TBL] [Abstract][Full Text] [Related]
10. Can the prediction model using regression with optimal scale improve the power to predict the Parkinson's dementia? Byeon H World J Psychiatry; 2022 Aug; 12(8):1031-1043. PubMed ID: 36158303 [TBL] [Abstract][Full Text] [Related]
11. A Single-institution Study on Predictors of Short-term Progression from Mild Cognitive Impairment in Parkinson's Disease to Parkinson's Disease with Dementia. Tajiri Y; Wada-Isoe K; Tanaka K; Adachi T; Hanajima R; Nakashima K Yonago Acta Med; 2020 Feb; 63(1):28-33. PubMed ID: 32158330 [TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803 [TBL] [Abstract][Full Text] [Related]
13. Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease. Liu Y; Qiu MY; Zhang YL; Zhang XJ; Truong D; Tan EK; Wu YC J Neurol Sci; 2021 Oct; 429():118060. PubMed ID: 34479167 [TBL] [Abstract][Full Text] [Related]
14. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Hobson P; Meara J Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160 [TBL] [Abstract][Full Text] [Related]
15. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Burdick DJ; Cholerton B; Watson GS; Siderowf A; Trojanowski JQ; Weintraub D; Ritz B; Rhodes SL; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Srivatsal S; Edwards KL; Montine TJ; Zabetian CP; Leverenz JB Mov Disord; 2014 Sep; 29(10):1258-64. PubMed ID: 25073717 [TBL] [Abstract][Full Text] [Related]
16. Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease. Behnke S; Pilotto A; Liepelt-Scarfone I; Yilmaz R; Pausch C; Dieterich S; Bürmann J; Spiegel J; Dillmann U; Unger M; Posner I; Berg D Parkinsonism Relat Disord; 2019 Sep; 66():68-73. PubMed ID: 31324557 [TBL] [Abstract][Full Text] [Related]
17. Determinants of Quality of Life According to Cognitive Status in Parkinson's Disease. Fan Y; Liang X; Han L; Shen Y; Shen B; Chen C; Sun Y; Wang J; Tang Y Front Aging Neurosci; 2020; 12():269. PubMed ID: 32973491 [TBL] [Abstract][Full Text] [Related]
18. Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708 [TBL] [Abstract][Full Text] [Related]
19. Dementia and functional decline in patients with Parkinson's disease. Stella F; Banzato CEM; Quagliato EMAB; Viana MA; Christofoletti G Dement Neuropsychol; 2008; 2(2):96-101. PubMed ID: 29213550 [TBL] [Abstract][Full Text] [Related]
20. Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study. Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; Pilati L; Restivo V; Zappia M; Monastero R Front Aging Neurosci; 2019; 11():21. PubMed ID: 30800065 [No Abstract] [Full Text] [Related] [Next] [New Search]